Clinical Trial Update: Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of combining zileuton with dasatinib in chronic myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Sprycel (dasatinib)
• ZYFLO (ZILEUTON)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Chronic Myelogenous Leukemia | Phase 1 | Status: TERMINATED